FEDERAL62d left

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

National Institutes of Health

Posted Oct 9, 2026

Deadline
Dec 14, 2026
62 days remaining
Amount
Up to $2M
Status
Open
Geographic Scope
National

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to characterize genomic variation to assess the impact of individual variants on genome function. This will be accomplished by systematically perturbing variants or elements using one or more high-throughput methods; collecting data on the effects of variants in DNA, RNA, or protein-coding elements on molecular, cellular, or organismal phenotypes; and developing robust, reproducible, and portable data processing pipelines. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers are also expected to collaborate with other consortium components to coordinate assays, variants, and cell types, and to develop shared analysis strategies to meet consortium goals.

AI Summary

This funding opportunity supports projects that aim to analyze genomic variations and their effects on genome function and phenotypes through high-throughput methods. Eligible applicants are research centers that will join the Impact of Genomic Variation on Function (IGVF) Consortium and collaborate with other members to share resources and strategies.

Funding Details

Maximum Award
$2,000,000

Key Dates

Posted: Oct 9, 2026Deadline: Dec 14, 2026

Quick Facts

CFDA Number
93.172
Funder Type
Federal Agency
Grant Level
FEDERAL
Last Verified
Oct 9, 2026

Geographic Scope

national

ReferenceGL-78EA57

78ea5767-7886-49be-85ac-13b006d74bc2

Intelligence

Ready to apply?

Visit the funder's website to start your application.